GlaxoSmithKline Extends HGS Offer To June 29

by Allie Wickman, Benzinga Staff Writer

June 8, 2012 8:34 AM | 23 seconds read | Make a Comment

GlaxoSmithKline plc

GSK

today announced it has extended its tender offer to acquire all of the outstanding shares of Human Genome Sciences

HGSI

for US$13.00 per share in cash to 5:00 p.m. New York City time on Friday, 29 June 2012. The tender offer was previously scheduled to expire at 12:00 midnight New York City time, at the end of the day on 7 June 2012.

Market News and Data brought to you by Benzinga APIs

Posted In: News M&A

Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

-

-

-

-

-

-

-

-

-

-

-

-

-

-

GlaxoSmithKline Extends HGS Offer To June 29